Within analgesics in France, OTC analgesics is recording underwhelming growth in 2024, attributable to several factors. For example, 2023-2024 has been seeing lower incidence of flu and common colds compared to 2022, and for a shorter period between autumn 2023 and winter 2024 thanks to milder temperatures and reduced rainfall - consequences of climate change.
The Analgesics in France report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. Forecasts to 2028 illustrate how the market is set to change.
Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.
Data coverage: Market sizes (historic and forecasts), company shares, brand shares and distribution data.
The Analgesics in France report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. Forecasts to 2028 illustrate how the market is set to change.
Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.
Data coverage: Market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
- Get a detailed picture of the Analgesics market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.
Table of Contents
KEY DATA FINDINGSCONSUMER HEALTH IN FRANCEDISCLAIMERDEFINITIONS
2024 DEVELOPMENTS
PROSPECTS AND OPPORTUNITIES
CATEGORY DATA
EXECUTIVE SUMMARY
MARKET INDICATORS
MARKET DATA
APPENDIX
SOURCES
